Livzon Pharmaceutical Group, Inc.

58
Hold
  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100001QV5
HKD
29.20
0.58 (2.03%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Livzon Pharmaceutical Group, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
3,056.00
3,031.00
2,568.00
2,638.00
2,659.00
2,795.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
65.00
-142.00
17.00
-144.00
-805.00
-412.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
3,447.00
3,247.00
3,750.00
3,376.00
2,411.00
2,478.00
Cash Flow from Investing Activities
-4,084.00
-701.00
-858.00
-1,582.00
-2,407.00
-571.00
Cash Flow from Financing Activities
-2,919.00
-2,727.00
-1,915.00
-837.00
-955.00
-587.00
Net Cash Inflow / Outflow
-3,662.00
-171.00
998.00
1,101.00
-996.00
1,233.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
-106.00
9.00
22.00
145.00
-44.00
-86.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Livzon Pharmaceutical Group, Inc.
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(HKD)
Change(%)
Profit Before Tax
3056.22323348007
79.3532588090562
2,977.00
3751.41%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
65.5922623891756
-353.523110310835
418.00
118.55%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
3447.67854481235
-163.897781376024
3,610.00
2203.55%
Cash Flow from Investing Activities
-4084.5309920578
-393.457242877958
-3,691.00
-938.11%
Cash Flow from Financing Activities
-2919.66988187557
548.411261777162
-3,467.00
-632.39%
Net Cash Inflow / Outflow
-3662.92842223468
-8.92858334302392
-3,654.00
-40924.74%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-106.406093113667
0.0151791337950619
-106.00
-701102.41%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
stock-summary

YoY Growth in year ended Dec 2025 is 6.17% vs -13.42% in Dec 2024

Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
3,447.68
3,247.35
6.17%